SAN RAMON, Calif., Jan. 27, 2017 -- Giga-tronics Incorporated (NASDAQ:GIGA) will release results for the third quarter of fiscal year 2017 on Monday February 6, 2016 after the close of trading on the NASDAQ Capital Market.
Also on February 6, 2017, Giga-tronics will host a conference call at 4:30 p.m. EST to discuss the results and provide an update on Company operations.
To participate in the call, dial: (800) 774-6070 or (630) 691-2753 and enter PIN Code 7913548#. It is recommended that you call in five to ten minutes prior to the start time. You may also listen to the call via the Giga-tronics website at www.gigatronics.com.
A replay of the call will be available later on the Giga-tronics website under “Investor Relations”. This conference call will reflect management views as of February 6, 2017 only.
Giga-tronics produces electronic warfare instruments used in the defense industry and YIG RADAR filters used in fighter jet aircraft.
Headquartered in San Ramon, California, Giga-tronics is a publicly held company, traded on the NASDAQ Capital Market under the symbol “GIGA”.
Contact: Temi Oduozor Corporate Controller (925) 302-1014 / [email protected]


Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



